LDE-225 (sonidegib)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LDE-225 (sonidegib), covering 2014-12-12 to 2014-12-12. Get the full timeline:
Most recent: Clinical Trial Update: A Pilot Study of a Hedgehog Pathway Inhibitor (LDE-225) in Surgically Resectable Pancreas Cancer [EARLY_Phase 1]